作者: Brian H. Cuthbertson , Charles L. Sprung , Djillali Annane , Sylvie Chevret , Mark Garfield
DOI: 10.1007/S00134-009-1603-4
关键词:
摘要: Rationale Use of etomidate in the critically ill is controversial due to its links with an inadequate response corticotropin and potential for excess mortality. In a septic shock population, we tested hypotheses that administration induces more non-responders increases mortality hydrocortisone treatment decreases patients receiving etomidate.